HOTTIP and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, the sensitivity of cells to Imatinib was altered by changing the expression level of HOTTIP, suggesting that HOTTIP plays an oncogene role in CML and is involved in IM resistance.